Intellia Therapeutics NTLA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.05M-9.5% | $23.02M+78.8% | $13.78M+51.3% | $14.25M+105% | $16.63M-42.5% | ||
| $80.74M-25.5% | $88.65M-24.1% | $94.75M-23.2% | $97.04M-15.0% | $108.43M-3.1% | ||
| $34.84M+20.1% | $33.08M+1.9% | $30.51M0.0% | $27.21M-14.4% | $29.01M-6.7% | ||
| $115.58M-15.9% | $121.73M-18.5% | $125.26M-18.6% | $124.24M-14.9% | $137.43M-3.9% | ||
| -$100.53M+16.8% | -$98.71M+27.7% | -$111.48M+23.0% | -$110M+20.9% | -$120.81M-6.0% | ||
| -668.1%+58.5pp | -428.9%+631pp | -808.9%+780pp | -772.2%+1,226pp | -726.6%-333pp | ||
| $5.21M-39.5% | $6.48M-39.1% | $6.71M-44.6% | $7.4M-40.4% | $8.6M-31.9% | ||
| $4.3M-33.6% | $2.92M-61.3% | $10.15M+12.1% | $8.74M+210% | $6.48M-1.4% | ||
| -$904K+57.5% | -$2.65M+13.9% | $3.44M+212% | $1.34M+107% | -$2.13M+65.0% | ||
| -$96.23M+15.8% | -$95.79M+25.7% | -$101.32M+25.3% | -$101.26M+31.1% | -$114.33M-6.4% | ||
| -639.5%+48.1pp | -416.2%+585pp | -735.2%+754pp | -710.8%+1,402pp | -687.6%-316pp | ||
| -$0.81+26.4% | -$0.82+34.9% | -$0.92+31.3% | -$0.98+35.5% | -$1.10+1.8% | ||
| -$0.81+26.4% | -$0.82+34.9% | -$0.92+31.3% | -$0.98+35.5% | -$1.10+1.8% | ||
| 118.5M+14.5% | 108.4M+9.6% | 110.2M+9.1% | 103.7M+7.0% | 103.5M+8.4% | ||
| 118.5M+14.5% | 108.4M+9.6% | 110.2M+9.1% | 103.7M+7.0% | 103.5M+8.4% | ||
| -$97.5M+14.4% | -$95.74M+27.2% | -$100.99M+23.1% | -$101.66M+30.9% | -$113.88M-5.2% | ||
| —— | -$0— | -$0— | -$0— | -$0— | ||
| $4.3M-33.6% | $2.92M-61.3% | $10.15M+12.1% | $8.74M+210% | $6.48M-1.4% | ||
| $15.05M-9.5% | $23.02M+78.8% | $13.78M+51.3% | $14.25M+105% | $16.63M-42.5% | ||
| -$100.53M+16.8% | -$98.71M+27.7% | -$111.48M+23.0% | -$110M+20.9% | -$120.81M-6.0% | ||
| -$98.33M+16.9% | -$96.33M+28.0% | -$109.08M+23.3% | -$107.5M+21.2% | -$118.31M-6.1% | ||
| -$98.33M+16.9% | -$96.33M+28.0% | -$109.08M+23.3% | -$107.5M+21.2% | -$118.31M-6.1% | ||
| -653.4%+58.1pp | -418.5%+621pp | -791.4%+769pp | -754.6%+1,207pp | -711.5%-326pp | ||
| -$100.53M+16.8% | -$98.71M+27.7% | -$111.48M+23.0% | -$110M+20.9% | -$120.81M-6.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Intellia Therapeutics's income statement data come from?
- Every line is extracted from Intellia Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.